Xanda Co., Ltd.: The company's annual sales target for the product Pyrazolium Quassine will be set based on the promotion progress.

2026-03-07 05:35:04

Securities Daily Online News: On March 5th, XianDa Co., Ltd. responded to investor questions on the interactive platform, stating that the company’s annual sales target for its innovative product, Pizolquazet, will be set based on promotional progress. By 2025, the product has been successfully launched and contributed to gross profit. As the promotion scale expands, it will become a new profit growth point.

(Editor: Ren Shibi)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.